Noncirrhotic Portal Hypertension: Current and Emerging Perspectives
- PMID: 31563222
- DOI: 10.1016/j.cld.2019.07.006
Noncirrhotic Portal Hypertension: Current and Emerging Perspectives
Abstract
Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction (EHPVO) are prototype noncirrhotic causes of portal hypertension (PHT), characterized by normal hepatic venous pressure gradient, variceal bleeds, and moderate to massive splenomegaly with preserved liver synthetic functions. Infections, toxins, and immunologic, prothrombotic and genetic disorders are possible causes in IPH, whereas prothrombotic and local factors around the portal vein lead to EHPVO. Growth failure, portal biliopathy, and minimal hepatic encephalopathy are long-term concerns in EHPVO. Surgical shunts and transjugular intrahepatic portosystemic shunt resolve the complications secondary to PHT. Meso-Rex shunt is now the standard-of-care surgery in children with EHPVO.
Keywords: Animal models; Biliopathy; Extrahepatic portal venous obstruction; Idiopathic portal hypertension; Parenchymal extinction; Rex shunt.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Idiopathic portal hypertension and extrahepatic portal venous obstruction.Hepatol Int. 2018 Feb;12(Suppl 1):148-167. doi: 10.1007/s12072-018-9844-3. Epub 2018 Feb 20. Hepatol Int. 2018. PMID: 29464506 Review.
-
Non-cirrhotic portal hypertension - diagnosis and management.J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Review.
-
Non-cirrhotic portal hypertension.Clin Liver Dis. 2014 May;18(2):451-76. doi: 10.1016/j.cld.2014.01.009. Clin Liver Dis. 2014. PMID: 24679506 Review.
-
Idiopathic portal hypertension: natural history and long-term outcome.Hepatology. 2014 Jun;59(6):2276-85. doi: 10.1002/hep.26904. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24155091
-
Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children.J Am Coll Surg. 2013 Jan;216(1):83-9. doi: 10.1016/j.jamcollsurg.2012.09.013. Epub 2012 Nov 21. J Am Coll Surg. 2013. PMID: 23177370
Cited by
-
A Case of Non-cirrhotic Portal Hypertension With Antiphospholipid Syndrome.Cureus. 2024 Feb 8;16(2):e53843. doi: 10.7759/cureus.53843. eCollection 2024 Feb. Cureus. 2024. PMID: 38465021 Free PMC article.
-
Updates in noncirrhotic portal hypertension.Clin Liver Dis (Hoboken). 2023 Jun 1;22(2):62-69. doi: 10.1097/CLD.0000000000000050. eCollection 2023 Aug. Clin Liver Dis (Hoboken). 2023. PMID: 37663549 Free PMC article. No abstract available.
-
Secondary Ammonia Scavenge With Glycerol Phenylbutyrate Improves Hyperammonemia Following Portosystemic Shunting.JPGN Rep. 2022 Jun 21;3(3):e210. doi: 10.1097/PG9.0000000000000210. eCollection 2022 Aug. JPGN Rep. 2022. PMID: 37168626 Free PMC article.
-
Histological Changes in Portal Cavernoma Cholangiopathy.Diagnostics (Basel). 2023 Jan 25;13(3):436. doi: 10.3390/diagnostics13030436. Diagnostics (Basel). 2023. PMID: 36766540 Free PMC article.
-
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature.Life (Basel). 2022 Nov 4;12(11):1781. doi: 10.3390/life12111781. Life (Basel). 2022. PMID: 36362936 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
